buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03
Published April 11, 2018 · Recall initiated: March 15, 2018
Summary
FDA records drug Class III recall D-0618-2018, published April 11, 2018 and initiated March 15, 2018. Recalling firm: InvaGen Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot# I1606579 and Lot# I1606580 Exp: 05/2018; Lot# I1612114 and Lot# I1612115 Exp: 11/2018. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications; during stability testing
What to do
Voluntary: Firm initiated · Letter
Get an email if BUPROPION HYDROCHLORIDE (SR) has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- BUPROPION HYDROCHLORIDE (SR)
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Distributor
- Nationwide
- UPC
- 0369097879037
- Lot
- Lot# I1606579 and Lot# I1606580 Exp: 05/2018; Lot# I1612114 and Lot# I1612115 Exp: 11/2018
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAbuPROPion HCl Extended-Release Tablets, USP (SR), 150 mg ,a) 60 count (NDC 69097-878-03) and b) 100 count (NDCApril 11, 2018
- FDAFabior (tazarotene) Foam, 0.1%, 100 grams can, Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834;April 11, 2018
- FDACoconut Smiles - Retail: International Harvest Brand Organic Go Smile! Dried Coconut Raw, in a 9 oz.April 11, 2018
- FDAHealthy Nut Factory ORGANIC COCONUT SMILES, Net Wt. 7 oz, UPC: 8 13449 02099 3April 11, 2018
- FDAIMRIS ORT300, Removable Operating Room Table, Part Numbers: (a) 114093-000 (b) 114093-600April 4, 2018
- FDAF-T3SYSTEM, T3 (Trumpf Table Top) System The device is a surgical table accessory system used to allow proneApril 4, 2018
Questions about this recall
Was buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03 recalled?
Yes. FDA published recall D-0618-2018 on April 11, 2018. Reported hazard: Failed Dissolution Specifications; during stability testing
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: BUPROPION HYDROCHLORIDE (SR). UPC: 0369097879037.